Clinical Trial Detail

NCT ID NCT02677038
Title Olaparib for BRCAness Phenotype in Pancreatic Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center
Indications

pancreatic adenocarcinoma

Therapies

Olaparib

Age Groups: senior adult

Additional content available in CKB BOOST